sb 203580 has been researched along with Embolism in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, WQ; Li, DH; Li, L; Qu, N; Wen, WM | 1 |
1 other study(ies) available for sb 203580 and Embolism
Article | Year |
---|---|
Coronary microembolization induced myocardial contractile dysfunction and tumor necrosis factor-α mRNA expression partly inhibited by SB203580 through a p38 mitogen-activated protein kinase pathway.
Topics: Animals; Blotting, Western; Coronary Disease; Echocardiography; Embolism; Imidazoles; Immunohistochemistry; Microcirculation; Myocardial Contraction; Myocardium; p38 Mitogen-Activated Protein Kinases; Pyridines; Random Allocation; Rats; Reverse Transcriptase Polymerase Chain Reaction; Tumor Necrosis Factor-alpha | 2011 |